IL17A and systemic lupus erythematosus: According to our meta-analysis, SLE patients exhibited greater levels of IL-17 (SMD=1.17; 95%CI=0.66,1.34; p<0.001; n=11; Figure 8), IL-21(SMD=2.42; 95%CI=0.73,4.11; p=0.005; n=4; Supplementary Figure D.12), and IL-6 (SMD=0.42; 95%CI=0.15,0.68; p=0.002; n=3; Figure 9) than HCs.